Rodrigo Refoios Camejo

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectiveness
    Rodrigo Refoios Camejo
    HTA Policy International Affairs, Pfizer Inc, Surrey, United Kingdom
    Value Health 15:381-8. 2012
  2. ncbi A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness
    Rodrigo Refoios Camejo
    Pfizer Inc, Surrey, UK
    Health Policy 100:18-24. 2011

Detail Information

Publications2

  1. ncbi Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectiveness
    Rodrigo Refoios Camejo
    HTA Policy International Affairs, Pfizer Inc, Surrey, United Kingdom
    Value Health 15:381-8. 2012
    ..The objective of this study is to provide an empirical basis for this discussion by estimating the potential for price decreases to impact on the cost-effectiveness of new therapies in hypertension...
  2. ncbi A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness
    Rodrigo Refoios Camejo
    Pfizer Inc, Surrey, UK
    Health Policy 100:18-24. 2011
    ..We conclude that disease-specific characteristics are an additional consideration in CE decision rules to accommodate the particularities of innovation across disease areas...